Bettina Cockroft
Director/Miembro de la Junta en ANNEXON, INC. .
Fortuna: - $ al 30/04/2024
Cargos activos de Bettina Cockroft
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ANNEXON, INC. | Director/Miembro de la Junta | 20/01/2022 | - |
| Independent Dir/Board Member | 20/01/2022 | - | |
| CNS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 08/05/2023 | - |
| Independent Dir/Board Member | 08/05/2023 | - | |
| Annexon Biosciences, Inc. | Director/Miembro de la Junta | - | - |
Historial de carrera de Bettina Cockroft
Antiguos cargos conocidos de Bettina Cockroft.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 30/09/2019 | 16/05/2023 |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/08/2017 | 01/09/2019 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Director Técnico/Científico/I+D | 01/09/2013 | 01/09/2016 |
Formación de Bettina Cockroft.
| MIT Sloan School of Management | Masters Business Admin |
| University of Genoa | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Italia | 2 |
| Suiza | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Independent Dir/Board Member | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ANNEXON, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
| Annexon Biosciences, Inc. |
- Bolsa de valores
- Insiders
- Bettina Cockroft
- Experiencia
